$PVCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PROVECTUS BIOPHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PROVECTUS BIOPHARMACEUTICALS, INC.. Get notifications about new insider transactions in PROVECTUS BIOPHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | PVCT | PROVECTUS BIOPHARM ... | Pershing Edward | Director | Option Exercise | M | 0.00 | 478,926 | 0 | 478,926 | |
Nov 12 2020 | PVCT | PROVECTUS BIOPHARM ... | Raines Heather | CFO | Grant | A | 0.00 | 50,000 | 0 | 1,213,153 | 1.2 M to 1.2 M (+4.30 %) |
Nov 12 2020 | PVCT | PROVECTUS BIOPHARM ... | Lacy John III | Director | Option Exercise | A | 0.29 | 100,000 | 28,620 | 100,000 | |
Nov 12 2020 | PVCT | PROVECTUS BIOPHARM ... | Lacy John III | Director | Grant | A | 0.00 | 100,000 | 0 | 200,000 | 100 K to 200 K (+100.00 %) |
Mar 27 2019 | PVCT | PROVECTUS BIOPHARM ... | Raines Heather | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 1,163,153 | 1.1 M to 1.2 M (+4.49 %) |
Dec 18 2017 | PVCT | PROVECTUS BIOPHARM ... | Glass John R | See Remarks | Buy | P | 0.05 | 115,900 | 6,259 | 200,000 | 84.1 K to 200 K (+137.81 %) |
Dec 18 2017 | PVCT | PROVECTUS BIOPHARM ... | Glass John R | See Remarks | Buy | P | 0.05 | 84,100 | 4,533 | 84,100 | 0 to 84.1 K |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 106,000 | 106,000 | 296,503 | 190.5 K to 296.5 K (+55.64 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 27,333 | 27,333 | 1,411,829 | 1.4 M to 1.4 M (+1.97 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 133,333 | 133,333 | 1,384,496 | 1.3 M to 1.4 M (+10.66 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | O | 0.85 | 306,947 | 260,905 | 306,947 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | O | 1.00 | 306,947 | 306,947 | 359,719 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | O | 1.00 | 106,000 | 106,000 | 930,248 | 824.2 K to 930.2 K (+12.86 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | O | 1.00 | 200,947 | 200,947 | 5,714,183 | 5.5 M to 5.7 M (+3.64 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 0.85 | 100,000 | 85,000 | 100,000 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 1.25 | 100,000 | 125,000 | 0 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 0.85 | 100,000 | 85,000 | 100,000 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | O | 1.25 | 100,000 | 125,000 | 0 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Buy | O | 1.25 | 100,000 | 125,000 | 786,300 | 686.3 K to 786.3 K (+14.57 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Buy | O | 1.25 | 100,000 | 125,000 | 686,300 | 586.3 K to 686.3 K (+17.06 %) |
Dec 22 2015 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | M | 1.02 | 120,000 | 122,400 | 120,000 | |
Dec 22 2015 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | M | 1.02 | 120,000 | 122,400 | 5,513,236 | 5.4 M to 5.5 M (+2.23 %) |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | M | 0.94 | 145,214 | 136,501 | 0 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | A | 0.75 | 400,000 | 300,000 | 400,000 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 0.94 | 6,383 | 6,000 | 190,503 | 184.1 K to 190.5 K (+3.47 %) |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 0.94 | 138,831 | 130,501 | 1,251,163 | 1.1 M to 1.3 M (+12.48 %) |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | A | 0.75 | 400,000 | 300,000 | 400,000 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | Smith Alfred E. IV | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 0.75 | 400,000 | 300,000 | 400,000 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 0.75 | 400,000 | 300,000 | 400,000 | |
Jan 26 2015 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | M | 1.02 | 185,000 | 188,700 | 800,000 | |
Jan 26 2015 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | M | 1.02 | 185,000 | 188,700 | 824,248 | 639.2 K to 824.2 K (+28.94 %) |
Jan 07 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | M | 0.94 | 29,786 | 27,999 | 145,214 | |
Jan 07 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | M | 0.75 | 33,334 | 25,001 | 0 | |
Jan 07 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 0.94 | 29,786 | 27,999 | 184,120 | 154.3 K to 184.1 K (+19.30 %) |
Jan 07 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 0.75 | 33,334 | 25,001 | 154,334 | 121 K to 154.3 K (+27.55 %) |
Jan 07 2015 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | M | 0.64 | 76,764 | 49,129 | 0 | |
Jan 07 2015 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Buy | M | 0.64 | 76,764 | 49,129 | 503,125 | 426.4 K to 503.1 K (+18.00 %) |
Dec 30 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | M | 0.64 | 126,361 | 80,871 | 76,764 | |
Dec 30 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Buy | M | 0.64 | 126,361 | 80,871 | 426,361 | 300 K to 426.4 K (+42.12 %) |
Oct 31 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | M | 0.64 | 96,875 | 62,000 | 203,125 | |
Oct 31 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Buy | M | 0.64 | 96,875 | 62,000 | 1,521,845 | 1.4 M to 1.5 M (+6.80 %) |
Oct 07 2014 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | J | 1.00 | 450,000 | 450,000 | 450,000 | |
Oct 07 2014 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | J | 0.93 | 450,000 | 418,500 | 450,000 | |
Oct 07 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | J | 1.00 | 475,000 | 475,000 | 475,000 | |
Oct 07 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | J | 0.93 | 475,000 | 441,750 | 475,000 | |
Oct 07 2014 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | CEO | Option Exercise | J | 1.00 | 475,000 | 475,000 | 475,000 | |
Oct 07 2014 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | CEO | Option Exercise | J | 0.93 | 475,000 | 441,750 | 475,000 | |
Jul 31 2014 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | A | 0.88 | 50,000 | 44,000 | 50,000 | |
Jul 31 2014 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | A | 0.88 | 50,000 | 44,000 | 50,000 | |
Jul 31 2014 | PVCT | PROVECTUS BIOPHARM ... | Smith Alfred E. IV | Director | Option Exercise | A | 0.88 | 50,000 | 44,000 | 50,000 | |
Jul 01 2014 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | M | 1.25 | 100,000 | 125,000 | 0 | |
Jul 01 2014 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 1.25 | 100,000 | 125,000 | 1,112,332 | 1 M to 1.1 M (+9.88 %) |
May 20 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | M | 0.95 | 25,000 | 23,750 | 0 | |
May 20 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Sell | M | 0.95 | 25,000 | 23,750 | 1,424,970 | 1.4 M to 1.4 M (-1.72 %) |
Mar 24 2014 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | M | 0.93 | 600,000 | 558,000 | 0 | |
Mar 24 2014 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | M | 0.75 | 14,248 | 10,686 | 0 | |
Mar 24 2014 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | M | 0.95 | 25,000 | 23,750 | 0 | |
Mar 24 2014 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | M | 0.93 | 600,000 | 558,000 | 6,032,484 | 5.4 M to 6 M (+11.04 %) |
Mar 24 2014 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | M | 0.75 | 14,248 | 10,686 | 5,432,484 | 5.4 M to 5.4 M (+0.26 %) |
Mar 24 2014 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | M | 0.95 | 25,000 | 23,750 | 5,418,236 | 5.4 M to 5.4 M (+0.46 %) |
Feb 28 2014 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | M | 1.10 | 189,624 | 208,586 | 0 | |
Feb 28 2014 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 1.10 | 121,000 | 133,100 | 121,000 | 0 to 121 K |
Feb 28 2014 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 1.10 | 68,624 | 75,486 | 1,012,332 | 943.7 K to 1 M (+7.27 %) |
Feb 28 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | M | 1.10 | 300,000 | 330,000 | 0 | |
Feb 28 2014 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Buy | M | 1.10 | 300,000 | 330,000 | 300,000 | 0 to 300 K |
Sep 24 2013 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | P | 1.00 | 150,000 | 150,000 | 150,000 | |
Sep 24 2013 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Buy | P | 0.00 | 100,000 | 0 | 586,300 | 486.3 K to 586.3 K (+20.56 %) |
Aug 21 2013 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | A | 0.67 | 50,000 | 33,500 | 50,000 | |
Aug 21 2013 | PVCT | PROVECTUS BIOPHARM ... | Smith Alfred E. IV | Director | Option Exercise | A | 0.67 | 50,000 | 33,500 | 50,000 | |
Aug 21 2013 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | A | 0.67 | 50,000 | 33,500 | 50,000 | |
Aug 21 2013 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 0.67 | 50,000 | 33,500 | 50,000 | |
Aug 21 2013 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 0.67 | 50,000 | 33,500 | 50,000 | |
May 30 2013 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.60 | 25,000 | 15,000 | 0 | |
May 30 2013 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 18,750 | 6,000 | 0 | |
May 30 2013 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.60 | 25,000 | 15,000 | 1,497,859 | 1.5 M to 1.5 M (+1.70 %) |
May 30 2013 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 18,750 | 6,000 | 1,472,859 | 1.5 M to 1.5 M (+1.29 %) |
Dec 03 2012 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO, COO | Option Exercise | P | 1.00 | 133,333 | 133,333 | 133,333 | |
Dec 03 2012 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO, COO | Buy | P | 0.00 | 133,333 | 0 | 943,708 | 810.4 K to 943.7 K (+16.45 %) |
Nov 20 2012 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Option Exercise | P | 1.00 | 666,666 | 666,666 | 666,666 | |
Nov 20 2012 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Chief Technology Of ... | Buy | P | 0.00 | 666,666 | 0 | 5,393,236 | 4.7 M to 5.4 M (+14.10 %) |
Nov 20 2012 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO, COO | Option Exercise | P | 1.00 | 133,333 | 133,333 | 133,333 | |
Nov 20 2012 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO, COO | Buy | P | 0.00 | 133,333 | 0 | 810,375 | 677 K to 810.4 K (+19.69 %) |
Jul 02 2012 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 0.84 | 50,000 | 42,000 | 50,000 | |
Jul 02 2012 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 0.84 | 50,000 | 42,000 | 50,000 | |
Jul 02 2012 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | A | 0.84 | 50,000 | 42,000 | 50,000 | |
Jul 02 2012 | PVCT | PROVECTUS BIOPHARM ... | Smith Alfred E. IV | Director | Option Exercise | A | 0.84 | 50,000 | 42,000 | 50,000 | |
Jul 02 2012 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | A | 1.25 | 100,000 | 125,000 | 100,000 | |
Jul 02 2012 | PVCT | PROVECTUS BIOPHARM ... | Koe Jan | Director | Option Exercise | A | 0.84 | 50,000 | 42,000 | 50,000 | |
Dec 07 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.75 | 100,000 | 75,000 | 14,248 | |
Dec 07 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.75 | 100,000 | 75,000 | 4,726,570 | 4.6 M to 4.7 M (+2.16 %) |
Dec 02 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.93 | 100,000 | 93,000 | 600,000 | |
Dec 02 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.93 | 100,000 | 93,000 | 4,626,570 | 4.5 M to 4.6 M (+2.21 %) |
Nov 28 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.93 | 100,000 | 93,000 | 700,000 | |
Nov 28 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.93 | 100,000 | 93,000 | 4,526,570 | 4.4 M to 4.5 M (+2.26 %) |
Oct 20 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.93 | 100,000 | 93,000 | 800,000 | |
Oct 20 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.93 | 100,000 | 93,000 | 4,426,570 | 4.3 M to 4.4 M (+2.31 %) |
Oct 06 2011 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | M | 0.60 | 25,000 | 15,000 | 0 | |
Oct 06 2011 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | M | 0.32 | 75,000 | 24,000 | 0 | |
Oct 06 2011 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Buy | M | 0.60 | 25,000 | 15,000 | 1,399,970 | 1.4 M to 1.4 M (+1.82 %) |
Oct 06 2011 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Buy | M | 0.32 | 75,000 | 24,000 | 1,374,970 | 1.3 M to 1.4 M (+5.77 %) |
Sep 07 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 0.93 | 1,000,000 | 930,000 | 1,000,000 | |
Sep 08 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.93 | 100,000 | 93,000 | 900,000 | |
Sep 08 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.93 | 100,000 | 93,000 | 4,326,570 | 4.2 M to 4.3 M (+2.37 %) |
Sep 07 2011 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 0.93 | 1,000,000 | 930,000 | 1,000,000 | |
Sep 07 2011 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 0.93 | 1,000,000 | 930,000 | 1,000,000 | |
Sep 07 2011 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | A | 0.93 | 1,000,000 | 930,000 | 1,000,000 | |
Jul 08 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jul 14 2011 | PVCT | PROVECTUS BIOPHARM ... | Smith Alfred E. IV | Director | Option Exercise | A | 0.99 | 50,000 | 49,500 | 50,000 | |
Aug 01 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 100,000 | 100,000 | 0 | |
Aug 01 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.00 | 100,000 | 100,000 | 4,226,570 | 4.1 M to 4.2 M (+2.42 %) |
Jul 08 2011 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jul 08 2011 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jul 08 2011 | PVCT | PROVECTUS BIOPHARM ... | FUCHS STUART | Director | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jul 08 2011 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
May 04 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 100,000 | 100,000 | 100,000 | |
May 04 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.00 | 100,000 | 100,000 | 4,126,570 | 4 M to 4.1 M (+2.48 %) |
May 04 2011 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 0.75 | 133,333 | 100,000 | 33,334 | |
May 04 2011 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 0.75 | 133,333 | 100,000 | 677,042 | 543.7 K to 677 K (+24.52 %) |
Apr 21 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 100,000 | 100,000 | 200,000 | |
Apr 21 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.00 | 100,000 | 100,000 | 4,026,570 | 3.9 M to 4 M (+2.55 %) |
Apr 13 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 50,000 | 50,000 | 0 | |
Apr 13 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 100,000 | 100,000 | 300,000 | |
Apr 13 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.00 | 150,000 | 150,000 | 3,926,570 | 3.8 M to 3.9 M (+3.97 %) |
Feb 08 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.75 | 8,333 | 6,250 | 114,248 | |
Feb 08 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.75 | 8,333 | 6,250 | 3,776,570 | 3.8 M to 3.8 M (+0.22 %) |
Feb 04 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.75 | 125,000 | 93,750 | 122,581 | |
Feb 04 2011 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.75 | 125,000 | 93,750 | 3,768,237 | 3.6 M to 3.8 M (+3.43 %) |
Dec 30 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 400,000 | 400,000 | 400,000 | |
Dec 30 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.00 | 400,000 | 400,000 | 3,643,237 | 3.2 M to 3.6 M (+12.33 %) |
Dec 30 2010 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 0.75 | 133,333 | 100,000 | 166,667 | |
Dec 30 2010 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 0.75 | 133,333 | 100,000 | 543,709 | 410.4 K to 543.7 K (+32.49 %) |
Nov 22 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 100,000 | 100,000 | 800,000 | |
Nov 22 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.00 | 100,000 | 100,000 | 3,243,237 | 3.1 M to 3.2 M (+3.18 %) |
Sep 07 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.00 | 100,000 | 100,000 | 900,000 | |
Sep 07 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.00 | 100,000 | 100,000 | 3,143,237 | 3 M to 3.1 M (+3.29 %) |
Jul 26 2010 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.00 | 1,000,000 | 1,000,000 | 1,000,000 | |
Jul 26 2010 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.00 | 1,000,000 | 1,000,000 | 1,000,000 | |
Jul 26 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 1.00 | 1,000,000 | 1,000,000 | 1,000,000 | |
Jul 26 2010 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | A | 1.00 | 1,000,000 | 1,000,000 | 1,000,000 | |
Jul 12 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.10 | 75,000 | 82,500 | 0 | |
Jul 12 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.10 | 75,000 | 82,500 | 3,043,237 | 3 M to 3 M (+2.53 %) |
Jun 18 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 1.16 | 50,000 | 58,000 | 50,000 | |
Jun 18 2010 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.16 | 50,000 | 58,000 | 50,000 |